Related Experiment Videos
[Hereditary gastrointestinal neoplasias]
1Klinik für Visceral-, Thorax- und Gefässchirurgie der Philipps-Universität Marburg.
Zeitschrift Fur Gastroenterologie
|February 9, 2005
Summary
Hereditary gastrointestinal cancers, including FAP, HNPCC, HDGC, and FPC, represent 5% of GI tumors. Understanding gene mutations aids in their prediction and prevention.
Area of Science:
- Gastroenterology and Medical Genetics
Context:
- Hereditary gastrointestinal tumors comprise about 5% of all gastrointestinal cancers.
- Advances in genetic mutation identification offer new avenues for predicting and preventing these hereditary conditions.
Purpose:
- To review the current knowledge on the epidemiology, clinical presentation, pathology, genetic basis, surveillance, and treatment of four major hereditary gastrointestinal cancer syndromes: familial adenomatous polyposis (FAP), hereditary non-polyposis colorectal cancer syndrome (HNPCC), hereditary diffuse gastric cancer (HDGC), and familial pancreatic cancer (FPC).
Summary:
- This review synthesizes current data on FAP, HNPCC, HDGC, and FPC.
- It covers their epidemiology, clinical and pathological features, genetic underpinnings, and current management strategies, including surveillance and treatment options.
Impact:
- Provides a comprehensive overview for clinicians and researchers managing hereditary gastrointestinal cancers.
- Highlights the importance of genetic insights in the personalized prediction and prevention of these diseases.